How to Get Rozex Online in Dublin

If you are looking to get Rozex online in Dublin, it is important to know how medical prescribing works before booking a consultation. Rozex is a brand name for standalone metronidazole 0.75% cream or gel; however, Hi-Doctor does not prescribe standalone Rozex. Instead, EU-licensed doctors assess your skin through an asynchronous medical questionnaire with photo upload and, when clinically appropriate, prescribe multi-ingredient compounded treatments containing metronidazole or standalone azelaic acid 15% gel. Consultations cost a 40 € one-off fee, a doctor reviews your case within 24 hours, and approved REMPE electronic prescriptions can be presented at any EU pharmacy.

Over 50,000 patients have completed consultations with Hi-Doctor, which maintains a 4.8/5 Trustpilot rating across Europe.

Key takeaways

• Formulary clarification: Hi-Doctor doctors do not prescribe brand-name Rozex. When clinically appropriate, doctors prescribe multi-active compounded topicals containing metronidazole or standalone azelaic acid 15% gel.
• Compounded formulation benefits: Compounding combines metronidazole with synergistic agents like niacinamide and azelaic acid to target multiple inflammatory mechanisms simultaneously.
• Transparent pricing: A 40 € one-off consultation fee applies. The 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
• Asynchronous review: A doctor reviews within 24 hours and issues a prescription when clinically appropriate, without requiring a video or telephone call.
• Cross-border prescription: The REMPE electronic prescription PDF can be presented at any EU pharmacy, where the pharmacist reviews it and may dispense a locally marketed equivalent. Pharmacists retain the right to refuse.

How it works — get your consultation in 4 steps

Patients in Dublin can complete the entire dermatology consultation online on any device:

1. Complete the medical questionnaire: Provide your dermatological history, known rosacea triggers, prior treatments, and current symptoms.
2. Upload skin photographs: Upload clear, close-up photos of your face so the doctor can accurately grade erythema and papulopustular lesions.
3. Doctor clinical assessment: An EU-licensed doctor evaluates your submission to determine if topical treatment is clinically appropriate.
4. Receive your REMPE prescription: If approved, the doctor issues an official REMPE electronic prescription PDF to your secure account in under 24 hours. You can present the PDF on your phone or print it for a pharmacy.

Who qualifies

Online rosacea consultations are intended for non-pregnant, non-breastfeeding adults in Ireland with mild-to-moderate facial symptoms. Eligibility is determined based on your medical questionnaire and photographic assessment:

• Erythematotelangiectatic rosacea: Persistent facial redness, flushing, and visible microvascular changes across the central face.
• Papulopustular rosacea: Inflammatory red bumps and small pustules localized to the cheeks, forehead, or chin.
• Patients needing topical therapy: Adults seeking prescription-grade topical formulas rather than systemic treatments.

Hi-Doctor provides topical treatments only. Severe, nodular, cystic, or scarring presentations, ocular rosacea, rhinophyma, oral antibiotics, and oral isotretinoin are out of scope and referred to in-person care.

What Rozex actually does

Rozex contains 0.75% metronidazole, a topical nitroimidazole antimicrobial and anti-inflammatory agent. It reduces oxidative stress, inhibits reactive oxygen species, and calms papules and pustules. While standalone metronidazole has been used for decades, modern clinical practice often uses compounded formulations that combine metronidazole with complementary active ingredients for multi-pathway management.

Formulation	Active Composition	Primary Clinical Focus	Expected Assessment Window
Compounded Erythema Cream	Metronidazole 0.75% + Niacinamide 4% + Azelaic Acid 10% + Allantoin 0.5%	Persistent central redness, flushing, and skin barrier sensitivity	4 to 8 weeks
Compounded Papulopustular Gel	Ivermectin 1% + Metronidazole 0.75% + Niacinamide 2%	Inflammatory papules, pustules, and Demodex mite proliferation	3 to 6 weeks
Azelaic Acid 15% Gel	Azelaic Acid 15%	Papulopustular rosacea, follicular plugging, and post-inflammatory erythema	4 to 12 weeks

Rosacea is a chronic vascular condition that is controlled rather than cured, and relapse is common after stopping treatment. Effective management requires combining prescribed topicals with daily trigger control, including limiting sun exposure, heat, alcohol, and spicy foods.

Side effects and when to stop

Topical rosacea treatments are generally well tolerated, with most reactions limited to mild, temporary cutaneous symptoms during the initial weeks of use:

• Common transient reactions: Mild stinging, transient burning, localized dryness, or slight flaking as the skin adapts.
• Supportive care: Use a gentle, fragrance-free moisturizer and apply broad-spectrum SPF 50 daily to protect the cutaneous barrier.
• When to discontinue: Stop applying the formula and seek immediate medical evaluation if you experience severe contact dermatitis, facial swelling, urticaria, or intense persistent burning.

Why Hi-Doctor vs. walking into a clinic

Booking a GP or dermatologist appointment in Dublin can involve lengthy waiting lists. Hi-Doctor offers an asynchronous, regulated consultation process handled under EU data-protection law (GDPR).

• 100% asynchronous: Complete the questionnaire and photo upload in your own time without waiting rooms, phone calls, or video appointments.
• Predictable cost: A single 40 € fee covers medical review and prescription issuance when clinically appropriate, with no recurring subscription.
• Clear refund policy: The 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
• EU cross-border standards: Prescriptions meet Commission Implementing Directive 2012/52/EU requirements and can be presented at any EU pharmacy, where the pharmacist reviews the prescription and may dispense a locally marketed equivalent under Directive 2011/24/EU.